VEGFA and cancer: Cancer presents one of the main pathologies for which AAT is used, due to the critical role of angiogenesis in cancer progression and metastasis.121 Currently approved AATs centre around blocking the key pro-angiogenic target VEGF, though other targets are emerging (Figure 4).